What Percent Of The World Has Hsv 2

What Percent Of The World Has Hsv 2

A password will be e-mailed to you.
Home Herpes Facts Herpes Statistics: How Common is Genital Herpes?
As an amazon associate, this site may earn from qualifying purchases.
We give you common compassion for a common condition. Our goal is to write researched guides with reputable sources, have them fact-checked by health practitioners, and provide citations where appropriate. New? Start here . Learn more About Us . Or just go straight to our list of useful herpes resources .

The only 100% natural blend that targets the real cause of outbreaks, and weakens and destroys the herpes virus through a 26 plant extract. Click here to get started now. (Ad)

© 2013-2020. Not medical advice, diagnosis or treatment.
Have You Tried the Herpesyl Formula?
The only 100% natural blend that targets the real cause of outbreaks, and weakens and destroys the herpes virus through a 26-plant extract.
1. Boost immune system
2. Destroy the virus' protective coat
3. Stop the virus from multiplying
By following the link above, you are leaving JustHerpes.com. Affiliate Disclosure . Terms of Use .
People are often surprised to learn how common genital herpes is. And looking at the data, about 48 million Americans would be in for a surprise if they got tested today. So how common is herpes? These genital herpes statistics focus on HSV-2 rates in the United States. Fortunately, the data also shows that herpes is highly manageable and people who have it can still have healthy love and sex lives.
Medically reviewed by Meagan Fleming, RN on Jan. 1, 2019 — Written by Editorial Staff
Planned Parenthood states that 1 in 6 Americans has genital herpes. ( 1 ) According to the American Sexual Health Organization, close to 90% of Americans don’t know they have genital herpes. ( 2 ) And according to the CDC, the statistic of infected people who don’t know is 87.4%. ( 3 )
► Herpesyl is a 100% natural blend that targets and eliminates herpes virus in the body. Click here to get started now.
► Positive Singles is a safe, supportive community to meet others with HSV ! Dating profiles, blogs, support groups, and active discussion. Avoid the awkward “herpes talk” — sign up free now .
Female genitals are more susceptible to infection due to their exposed soft tissue.
An interesting note about HSV-2 transmission is that it’s often contracted within long-term relationships rather than through other high-risk considerations ( 9 ).
According to studies done by Valtrex, these are the rates of transmission per year of regular sex :
Though this article focuses on genital herpes caused by HSV-2, oral herpes is extremely common. In fact, many cases of genital herpes are caused by oral herpes, nothing more than a cold sore or contagious period that passed to the genitals through oral sex.
The big takeaways from these numbers are that:
1. Herpes is more common than many might think , and a lot of people are unaware they are infected and may not even have symptoms to tip them off. Unfortunately, when clinicians give “standard” STI check-ups, they don’t include tests for HSV-1 or HSV-2, unless it is specifically requested.
2. Many couples have a healthy sex life and still never transmit it to the uninfected partner. Taking precautions like avoiding sex during and around the time of an outbreak, using condoms and taking antiviral medication like valacyclovir (Valtrex) or Acyclovir drastically reduces the likelihood of transmission. The statistics indicate that it’s possible to get your chances of transmitting HSV-2 down to as low as 2.1% with condoms and antiviral medications.
3. Take charge of your sexual health and get regularly screened for STIs. You can specifically request a herpes test if the practitioner does not include it in standard checkups and you feel you need treatment. You can even order tests online:
Note: Not all genital herpes statistics are consistent from study to study. Most say 25% of American women have the virus, and 20% of American males. Other studies show slightly lower numbers. The studies with slightly lower numbers refer to people from 14 to 49 , while the higher number studies are based on all people over 12 . As populations age, there is a higher incidence of STIs.
► Herpesyl is a 100% natural blend that targets and eliminates herpes virus in the body. Click here to get started now.
Positive Singles is a safe, supportive community to meet others with HSV! Profiles, blogs, forums, Q&As and more. Check it out FREE here .
Herpes is not the end — 3 out of 4 of us have a type. Get common compassion for a common condition. Most articles are medically reviewed. It’s just herpes!
Positive Singles is a safe, supportive community to meet others with HSV! Profiles, blogs, forums, Q&As and more. Check it out FREE here .
myLab Box will send you a mail-in STI test kit that’s private and 100% pain free. Pick the kit you like here !
STDcheck lets you order any STI test and go to a lab near you for same-day testing. Click here for our coupon and get peace of mind today!
You can support us by using the links on the Herpes Resources page.
Information on this site is general in nature and cannot take the place of medical evaluation, diagnoses, and treatment by a health care provider. These statements have not been evaluated by the Food and Drug Administration.

Dashboard
Publications
Account settings
Log out

Journal List

Bull World Health Organ

v.98(5); 2020 May 1

PMC7265941

Bull World Health Organ. 2020 May 1; 98(5): 315–329.
Published online 2020 Mar 25. doi: 10.2471/BLT.19.237149
Find articles by Laith J Abu-Raddad
Find articles by Katharine J Looker
a Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, England.
b Weill Cornell Medical College, Doha, Qatar.
c Bristol Veterinary School, University of Bristol, Bristol, England.
d Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Correspondence to Katharine J Looker (email: ku.ca.lotsirb@rekool.enirahtak ).
Received 2019 May 13; Revised 2020 Jan 21; Accepted 2020 Jan 21.
Copyright (c) 2020 The authors; licensee World Health Organization.
This is an open access article distributed under the terms of the Creative Commons Attribution IGO License ( http://creativecommons.org/licenses/by/3.0/igo/legalcode ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.
This article has been cited by other articles in PMC.
Global and regional estimates of the prevalence of herpes simplex virus type 2 infections by age and sex, 2016
Global and regional estimates of the prevalence of oral herpes simplex virus type 1 infection by age and sex, 2016
Global and regional estimates of the prevalence of genital herpes simplex virus type 1 infection by age and sex, 2016
Global and regional estimates of the incidence of herpes simplex virus type 2 infection by age and sex, 2016
Global and regional estimates of the incidence of herpes simplex virus type 1 infection (at any site) by age and sex, 2016
1. Looker KJ, Magaret AS, May MT, Turner KME, Vickerman P, Gottlieb SL, et al.
Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012.
PLoS One . 2015.
October
28; 10 ( 10 ):e0140765. 10.1371/journal.pone.0140765 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
2. Looker KJ, Magaret AS, Turner KME, Vickerman P, Gottlieb SL, Newman LM. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012.
PLoS One . 2015.
January
21; 10 ( 1 ):e114989. 10.1371/journal.pone.0114989 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
3. Higgins CR, Schofield JK, Tatnall FM, Leigh IM. Natural history, management and complications of herpes labialis.
J Med Virol . 1993; 41 ( S1 ) Suppl 1:22–6. 10.1002/jmv.1890410506 [ PubMed ] [ CrossRef ] [ Google Scholar ]
4. Whitley R, Baines J. Clinical management of herpes simplex virus infections: past, present, and future.
F1000 Res . 2018.
October
31; 7 :1726. 10.12688/f1000research.16157.1 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
5. Ayoub HH, Chemaitelly H, Abu-Raddad LJ. Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions.
BMC Med . 2019.
March
11; 17 ( 1 ):57. 10.1186/s12916-019-1285-x [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
6. Tuokko H, Bloigu R, Hukkanen V. Herpes simplex virus type 1 genital herpes in young women: current trend in Northern Finland.
Sex Transm Infect . 2014.
March; 90 ( 2 ):160. 10.1136/sextrans-2013-051453 [ PubMed ] [ CrossRef ] [ Google Scholar ]
7. Brijwal M, Rawre J, Dhawan B, Khanna N, Choudhary A, Dar L. Herpes simplex virus type 1 genital ulcer disease at a tertiary care hospital in north India.
Clin Infect Dis . 2019.
May
2; 68 ( 10 ):1783–4. 10.1093/cid/ciy943 [ PubMed ] [ CrossRef ] [ Google Scholar ]
8. Khadr L, Harfouche M, Omori R, Schwarzer G, Chemaitelly H, Abu-Raddad LJ. The epidemiology of herpes simplex virus type 1 in Asia: systematic review, meta-analyses, and meta-regressions.
Clin Infect Dis . 2019.
February
15; 68 ( 5 ):757–72. 10.1093/cid/ciy562 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
9. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection.
Ann Intern Med . 1994.
December
1; 121 ( 11 ):847–54. 10.7326/0003-4819-121-11-199412010-00004 [ PubMed ] [ CrossRef ] [ Google Scholar ]
10. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications.
Ann Intern Med . 1983.
June; 98 ( 6 ):958–72. 10.7326/0003-4819-98-6-958 [ PubMed ] [ CrossRef ] [ Google Scholar ]
11. Gupta R, Warren T, Wald A. Genital herpes.
Lancet . 2007.
December
22; 370 ( 9605 ):2127–37. 10.1016/S0140-6736(07)61908-4 [ PubMed ] [ CrossRef ] [ Google Scholar ]
12. Pinninti SG, Kimberlin DW. Maternal and neonatal herpes simplex virus infections.
Am J Perinatol . 2013.
February; 30 ( 2 ):113–20. 10.1055/s-0032-1332802 [ PubMed ] [ CrossRef ] [ Google Scholar ]
13. Looker KJ, Elmes JAR, Gottlieb SL, Schiffer JT, Vickerman P, Turner KME, et al.
Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis.
Lancet Infect Dis . 2017.
December; 17 ( 12 ):1303–16. 10.1016/S1473-3099(17)30405-X [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
14. Ramchandani M, Kong M, Tronstein E, Selke S, Mikhaylova A, Magaret A, et al.
Herpes simplex virus type 1 shedding in tears and nasal and oral mucosa of healthy adults.
Sex Transm Dis . 2016.
December; 43 ( 12 ):756–60. 10.1097/OLQ.0000000000000522 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
15. Mark KE, Wald A, Magaret AS, Selke S, Olin L, Huang M-L, et al.
Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults.
J Infect Dis . 2008.
October
15; 198 ( 8 ):1141–9. 10.1086/591913 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
16. Looker KJ, Garnett GP, Schmid GP. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection.
Bull World Health Organ . 2008.
October; 86 ( 10 ):805–12. 10.2471/BLT.07.046128 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
17. Collaborators Global Burden of Disease; Global Burden of Disease 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017.
Lancet . 2018.
November
10; 392 ( 10159 ):1789–858. 10.1016/S0140-6736(18)32279-7 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
18. Global health sector strategy on sexually transmitted infections 2016–2021. Towards ending sexually transmitted infections. WHO/RHR/16.09. Geneva: World Health Organization; 2016. Available from: https://www.who.int/reproductivehealth/publications/rtis/ghss-stis/en/ [cited 2019 Dec 11].
19. Gottlieb SL, Low N, Newman LM, Bolan G, Kamb M, Broutet N. Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines.
Vaccine . 2014.
March
20; 32 ( 14 ):1527–35. 10.1016/j.vaccine.2013.07.087 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
20. Gottlieb SL, Deal CD, Giersing B, Rees H, Bolan G, Johnston C, et al.
The global roadmap for advancing development of vaccines against sexually transmitted infections: update and next steps.
Vaccine . 2016.
June
3; 34 ( 26 ):2939–47. 10.1016/j.vaccine.2016.03.111 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
21. Gottlieb SL, Giersing BK, Hickling J, Jones R, Deal C, Kaslow DC; HSV Vaccine Expert Consultation Group. Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017.
Vaccine . 2019.
November
28; 37 ( 50 ):7408–18. 10.1016/j.vaccine.2017.10.084 [ PubMed ] [ CrossRef ] [ Google Scholar ]
22. Looker KJ, Magaret AS, May MT, Turner KME, Vickerman P, Newman LM, et al.
First estimates of the global and regional incidence of neonatal herpes infection.
Lancet Glob Health . 2017.
March; 5 ( 3 ):e300–9. 10.1016/S2214-109X(16)30362-X [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
23. James C, Harfouche M, Welton NJ, Turner KME, Abu-Raddad LJ, Gottlieb SL et al. Supplementary webappendix: data from 2016 HSV infection estimates (02-2020). [data repository]. Bristol: University of Bristol; 2019. 10.5523/bris.w4tr95py62gh2v32ep33dahtx 10.5523/bris.w4tr95py62gh2v32ep33dahtx [ CrossRef ] [ CrossRef ]
24. World population prospects 2017 [internet]. New York: United Nations; 2017. Available from: https://population.un.org/wpp/Download/Standard/Population/ [cited 2019 Mar 19].
25. Bernstein DI, Bellamy AR, Hook EW 3rd, Levin MJ, Wald A, Ewell MG, et al.
Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women.
Clin Infect Dis . 2013.
February; 56 ( 3 ):344–51. 10.1093/cid/cis891 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
26. Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley RL, et al.
The acquisition of herpes simplex virus during pregnancy.
N Engl J Med . 1997.
August
21; 337 ( 8 ):509–16. 10.1056/NEJM199708213370801 [ PubMed ] [ CrossRef ] [ Google Scholar ]
27. Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE; Chiron HSV Vaccine Study Group. A prospective study of new infections with herpes simplex virus type 1 and type 2.
N Engl J Med . 1999.
November
4; 341 ( 19 ):1432–8. 10.1056/NEJM199911043411904 [ PubMed ] [ CrossRef ] [ Google Scholar ]
28. Mertz GJ, Ashley R, Burke RL, Benedetti J, Critchlow C, Jones CC, et al.
Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection.
J Infect Dis . 1990.
April; 161 ( 4 ):653–60. 10.1093/infdis/161.4.653 [ PubMed ] [ CrossRef ] [ Google Scholar ]
29. National Health and Nutrition Examination Surveys. 1976 to 2016 [internet]. Atlanta: Centers for Disease Control and Prevention; 2016. Available from: https://wwwn.cdc.gov/nchs/nhanes/Default.aspx [cited 2019 Dec 10].
30. Chaabane S, Harfouche M, Chemaitelly H, Schwarzer G, Abu-Raddad LJ. Herpes simplex virus type 1 epidemiology in the Middle East and North Africa: systematic review, meta-analyses, and meta-regressions.
Sci Rep . 2019.
February
4; 9 ( 1 ):1136. 10.1038/s41598-018-37833-8 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
31. Sukik L, Alyafei M, Harfouche M, Abu-Raddad LJ. Herpes simplex virus type 1 epidemiology in Latin America and the Caribbean: systematic review and meta-analytics.
PLoS One . 2019.
April
22; 14 ( 4 ):e0215487. 10.1371/journal.pone.0215487 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
32. Abbai NS, Wand H, Ramjee G. Socio-demographic and behavioural characteristics associated with HSV-2 sero-prevalence in high risk women in KwaZulu-Natal.
BMC Res Notes . 2015.
May
5; 8 ( 1 ):185. 10.1186/s13104-015-1093-0 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
33. Abdool Karim Q, Kharsany AB, Leask K, Ntombela F, Humphries H, Frohlich JA, et al.
Prevalence of HIV, HSV-2 and pregnancy among high school students in rural KwaZulu-Natal, South Africa: a bio-behavioural cross-sectional survey.
Sex Transm Infect . 2014.
December; 90 ( 8 ):620–6. 10.1136/sextrans-2014-051548 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
34. Abdool Karim SS, Abdool Karim Q, Kharsany AB, Baxter C, Grobler AC, Werner L, et al.; CAPRISA 004 Trial Group. Tenofovir gel for the prevention of herpes simplex virus type 2 infection.
N Engl J Med . 2015.
August
6; 373 ( 6 ):530–9. 10.1056/NEJMoa1410649 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
35. Akinyi B, Odhiambo C, Otieno F, Inzaule S, Oswago S, Kerubo E, et al.
Prevalence, incidence and correlates of HSV-2 infection in an HIV incidence adolescent and adult cohort study in western Kenya.
PLoS One . 2017.
June
6; 12 ( 6 ):e0178907. 10.1371/journal.pone.0178907 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
36. Anjulo AA, Abebe T, Hailemichael F, Mihret A. Seroprevalence and risk factors of herpes simplex virus type 2 among pregnant women attending antenatal care at health facilities in Wolaita zone, Ethiopia.
Virol J . 2016.
March
15; 13 ( 1 ):43. 10.1186/s12985-016-0501-y [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
37. Behling J, Chan AK, Zeh C, Nekesa C, Heinzerling L. Evaluating HIV prevention programs: herpes simplex virus type 2 antibodies as biomarker for sexual risk behavior in young adults in resource-poor countries.
PLoS One . 2015.
May
26; 10 ( 5 ):e0128370. 10.1371/journal.pone.0128370 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
38. Bradley J, Floyd S, Piwowar-Manning E, Laeyendecker O, Young A, Bell-Mandla N, et al.; HPTN 071 (PopART) Study Team. Sexually transmitted bedfellows: exquisite association between HIV and herpes simplex virus type 2 in 21 communities in Southern Africa in the HIV prevention trials network 071 (PopART) Study.
J Infect Dis . 2018.
July
2; 218 ( 3 ):443–52. 10.1093/infdis/jiy178 [ PMC free article ] [ PubMed ] [ CrossRef ] [ Google Scholar ]
39. Chattopadhyay K, Williamson AL, Hazra A, Dandara C. The combined risks of reduced or increased function variants in cell death pathway g
Cum Inside Sleeping Sister
Bundy Erotic Fan Fic
Textfiles Erotica

What Percent Of The World Has Hsv 2

Report Page